These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 22487610)

  • 41. [Correlation of fibroblast growth factor 23 with 
adverse prognosis of chronic kidney disease and
therapy strategy].
    Liu H; Liu H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 May; 43(5):560-565. PubMed ID: 29886473
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correlates and Longitudinal Renal and Cardiovascular Implications of FGF23 Levels in HIV-Positive Individuals.
    Atta MG; Estrella MM; Fine DM; Zook K; Monroy Trujillo JM; Stein JH; Lucas GM
    PLoS One; 2016; 11(5):e0155312. PubMed ID: 27176000
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fibroblast growth factor 23 as a predictor of cardiovascular and all-cause mortality in prospective studies.
    Qin Z; Liu X; Song M; Zhou Q; Yu J; Zhou B; Wu Y; He Y; Huang L
    Atherosclerosis; 2017 Jun; 261():1-11. PubMed ID: 28411494
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association between FGF23, α-Klotho, and Cardiac Abnormalities among Patients with Various Chronic Kidney Disease Stages.
    Tanaka S; Fujita S; Kizawa S; Morita H; Ishizaka N
    PLoS One; 2016; 11(7):e0156860. PubMed ID: 27400031
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Earlier onset and greater severity of disordered mineral metabolism in diabetic patients with chronic kidney disease.
    Wahl P; Xie H; Scialla J; Anderson CA; Bellovich K; Brecklin C; Chen J; Feldman H; Gutierrez OM; Lash J; Leonard MB; Negrea L; Rosas SE; Anderson AH; Townsend RR; Wolf M; Isakova T;
    Diabetes Care; 2012 May; 35(5):994-1001. PubMed ID: 22446176
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Correlations of FGF23 and Klotho with cardiovascular injury in chronic kidney disease patients].
    Gan L; Zhou Q
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Sep; 42(9):1058-1065. PubMed ID: 28989152
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.
    Moe SM; Chertow GM; Parfrey PS; Kubo Y; Block GA; Correa-Rotter R; Drüeke TB; Herzog CA; London GM; Mahaffey KW; Wheeler DC; Stolina M; Dehmel B; Goodman WG; Floege J;
    Circulation; 2015 Jul; 132(1):27-39. PubMed ID: 26059012
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fibroblast Growth Factor 23 Predicts Mortality and End-Stage Renal Disease in a Canadian Asian Population with Chronic Kidney Disease.
    Jialal I; Camacho F; Nathoo B; Tam P; Pahwa R; Wu GG
    Nephron; 2017; 137(3):190-196. PubMed ID: 28743129
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New insights into the role of fibroblast growth factor 23 in chronic kidney disease.
    Nakai K; Komaba H; Fukagawa M
    J Nephrol; 2010; 23(6):619-25. PubMed ID: 20658451
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Forging forward with 10 burning questions on FGF23 in kidney disease.
    Wolf M
    J Am Soc Nephrol; 2010 Sep; 21(9):1427-35. PubMed ID: 20507943
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of Fibroblast Growth Factor-23 Levels and Angiotensin-Converting Enzyme Inhibition in Chronic Systolic Heart Failure.
    Wohlfahrt P; Melenovsky V; Kotrc M; Benes J; Jabor A; Franekova J; Lemaire S; Kautzner J; Jarolim P
    JACC Heart Fail; 2015 Oct; 3(10):829-39. PubMed ID: 26450001
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fibroblast Growth Factor 23 and Adverse Clinical Outcomes in Type 2 Diabetes: a Bitter-Sweet Symphony.
    Yeung SMH; Bakker SJL; Laverman GD; De Borst MH
    Curr Diab Rep; 2020 Aug; 20(10):50. PubMed ID: 32857288
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Klotho and endocrine fibroblast growth factors: markers of chronic kidney disease progression and cardiovascular complications?
    Kuro-O M
    Nephrol Dial Transplant; 2019 Jan; 34(1):15-21. PubMed ID: 29800324
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dialysis vintage and parathyroid hormone level, not fibroblast growth factor-23, determines chronic-phase phosphate wasting after renal transplantation.
    Tomida K; Hamano T; Ichimaru N; Fujii N; Matsui I; Nonomura N; Tsubakihara Y; Rakugi H; Takahara S; Isaka Y
    Bone; 2012 Oct; 51(4):729-36. PubMed ID: 22796419
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The elevation of circulating fibroblast growth factor 23 without kidney disease does not increase cardiovascular disease risk.
    Pastor-Arroyo EM; Gehring N; Krudewig C; Costantino S; Bettoni C; Knöpfel T; Sabrautzki S; Lorenz-Depiereux B; Pastor J; Strom TM; Hrabě de Angelis M; Camici GG; Paneni F; Wagner CA; Rubio-Aliaga I
    Kidney Int; 2018 Jul; 94(1):49-59. PubMed ID: 29735309
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease.
    Gutiérrez OM; Januzzi JL; Isakova T; Laliberte K; Smith K; Collerone G; Sarwar A; Hoffmann U; Coglianese E; Christenson R; Wang TJ; deFilippi C; Wolf M
    Circulation; 2009 May; 119(19):2545-52. PubMed ID: 19414634
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fibroblast growth factor 23 is associated with proteinuria and smoking in chronic kidney disease: an analysis of the MASTERPLAN cohort.
    Vervloet MG; van Zuilen AD; Heijboer AC; ter Wee PM; Bots ML; Blankestijn PJ; Wetzels JF;
    BMC Nephrol; 2012 Apr; 13():20. PubMed ID: 22530966
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum fibroblast growth factor-23 and risk of incident chronic kidney disease in older community-dwelling women.
    Semba RD; Fink JC; Sun K; Cappola AR; Dalal M; Crasto C; Ferrucci L; Fried LP
    Clin J Am Soc Nephrol; 2012 Jan; 7(1):85-91. PubMed ID: 22076875
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vitamin D and renal outcome: the fourth outcome of CKD-MBD? Oshima Award Address 2015.
    Hamano T
    Clin Exp Nephrol; 2018 Apr; 22(2):249-256. PubMed ID: 29270765
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Circulating fibroblast growth factor-23 is associated with fat mass and dyslipidemia in two independent cohorts of elderly individuals.
    Mirza MA; Alsiö J; Hammarstedt A; Erben RG; Michaëlsson K; Tivesten A; Marsell R; Orwoll E; Karlsson MK; Ljunggren O; Mellström D; Lind L; Ohlsson C; Larsson TE
    Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):219-27. PubMed ID: 20966399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.